Niclas Adler

Niclas Adler currently works at Synthesis Analytics Production Ltd., as Chief Executive Officer & Director from 2022, Akinion Pharmaceuticals AB, as Chairman, e-Cognition Pte Ltd., as Chairman, PT Accelerated Value, as Chairman, Accelerated Drug Development AB, as Chairman, SCI Innovation AB, as Director, Ao Holding AB, as Director, Babson College, as Professor-Entrepreneurship Practice, and Indonesia International Institute For Life Sciences, as President.
Dr. Adler also formerly worked at Jönköping International Business School, as Chief Executive Officer, Ith Immune Therapy Holdings AB, as Chairman, TLA Targeted Immunotherapies AB, as Chairman, TRUPOINT Partners, Inc., as Director, Karolinska Development AB, as Independent Director from 2015 to 2017, Stockholm School of Entrepreneurship, as Executive Director, EdgeMode, Inc., as Director & Chief Technology Officer in 2025, and IPMI Business School, as President.
Dr. Adler received his graduate degree in 1994 and doctorate degree in 1999 from Stockholm School of Economics.